DHR Danaher Corporation

Price (delayed)

$204.86

Market cap

$145.33B

P/E Ratio

43.13

Dividend/share

$0.7

EPS

$4.75

Enterprise value

$162.18B

Sector: Healthcare
Industry: Diagnostics & Research
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Highlights

The net income has increased by 40% year-on-year and by 6% since the previous quarter
DHR's EPS is up by 39% year-on-year and by 6% since the previous quarter
The quick ratio has surged by 73% since the previous quarter but it has declined by 47% year-on-year
The debt is up by 27% year-on-year but it has declined by 14% since the previous quarter
The price to earnings (P/E) is 55% more than the 5-year quarterly average of 27.8 and 18% more than the last 4 quarters average of 36.7

Key stats

What are the main financial stats of DHR
Market
Shares outstanding
709.41M
Market cap
$145.33B
Enterprise value
$162.18B
Valuations
Price to earnings (P/E)
43.13
Price to book (P/B)
3.94
Price to sales (P/S)
8.25
EV/EBIT
36.97
EV/EBITDA
28.49
EV/Sales
9.26
Earnings
Revenue
$17.52B
EBIT
$4.39B
EBITDA
$5.69B
Free cash flow
$3.76B
Per share
EPS
$4.75
Free cash flow per share
$5.33
Book value per share
$51.99
Revenue per share
$24.84
TBVPS
$24.96
Balance sheet
Total assets
$71.27B
Total liabilities
$35B
Debt
$22.39B
Equity
$36.26B
Working capital
$6.74B
Liquidity
Debt to equity
0.62
Current ratio
2.2
Quick ratio
1.59
Net debt/EBITDA
2.96
Margins
EBITDA margin
32.5%
Gross margin
55.3%
Net margin
19.8%
Operating margin
18.3%
Efficiency
Return on assets
5.1%
Return on equity
10.4%
Return on invested capital
16.4%
Return on capital employed
6.7%
Return on sales
25%
Dividend
Dividend yield
0.34%
DPS
$0.7
Payout ratio
14.7%

DHR stock price

How has the Danaher stock price performed over time

Financial performance

How have Danaher's revenue and profit performed over time
Revenue
$17.52B
Gross profit
$9.68B
Operating income
$3.2B
Net income
$3.47B
Gross margin
55.3%
Net margin
19.8%
The net income has increased by 40% year-on-year and by 6% since the previous quarter
The net margin is up by 29% year-on-year
Danaher's revenue has increased by 8% YoY and by 5% from the previous quarter
The gross profit is up by 8% year-on-year and by 4% since the previous quarter

Valuation

What is Danaher stock price valuation
P/E
43.13
P/B
3.94
P/S
8.25
EV/EBIT
36.97
EV/EBITDA
28.49
EV/Sales
9.26
The price to earnings (P/E) is 55% more than the 5-year quarterly average of 27.8 and 18% more than the last 4 quarters average of 36.7
DHR's EPS is up by 39% year-on-year and by 6% since the previous quarter
The P/B is 46% more than the 5-year quarterly average of 2.7 and 19% more than the last 4 quarters average of 3.3
The equity has grown by 17% from the previous quarter and by 12% YoY
DHR's P/S is 76% above its 5-year quarterly average of 4.7 and 31% above its last 4 quarters average of 6.3
Danaher's revenue has increased by 8% YoY and by 5% from the previous quarter

Efficiency

How efficient is Danaher business performance
Danaher's ROE has increased by 33% YoY and by 3% from the previous quarter
DHR's return on sales is up by 20% year-on-year and by 4.6% since the previous quarter
DHR's ROA is up by 13% year-on-year
The return on invested capital has declined by 12% year-on-year and by 3% since the previous quarter

Dividends

What is DHR's dividend history
DPS
$0.7
Dividend yield
0.34%
Payout ratio
14.7%
Recent dividends

Financial health

How did Danaher financials performed over time
The total assets is 104% greater than the total liabilities
The quick ratio has surged by 73% since the previous quarter but it has declined by 47% year-on-year
The current ratio has surged by 67% since the previous quarter but it has declined by 36% year-on-year
The debt is 38% smaller than the equity
The debt is up by 27% year-on-year but it has declined by 14% since the previous quarter
Danaher's debt to equity has decreased by 26% from the previous quarter but it has increased by 15% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.